© 2022 SB Investment Advisers (UK) Limited


    Perspectives from inside our ecosystem

    Be humble and keep learning

    Join Cohesity’s Mohit Aron as he explains the importance of learning from mistakes while building world-class solutions to simplify data management.

    Inside the SoftBank Vision Fund portfolio ecosystem

    At The Milken Institute Middle East & Africa Summit 2020, Rajeev Misra and Michael Milken discuss how our global ecosystem helps companies scale and become market-leading companies.

    Covid-19 impacts on venture capital and investing

    At India Global Week 2020, Deep Nishar and other industry leaders examine the economic disruption resulting from Covid-19 and their perspectives on emerging investment opportunities for VC firms.

    Covid-19’s impact on technology

    At The Milken Institute Summer Series 2020, Rajeev Misra and Michael Milken discuss how Covid-19 has impacted a variety of business sectors across the globe by accelerating tech innovation and reshaping business sectors such as finance and real estate at large.

    Leadership during a crisis: responding to Covid-19

    In this episode of Outliers, Deep Nishar discusses the practical and emotional challenges of leadership during uncertain times. Hear his perspective on the tactical ways founders can navigate uncertainty and emerge through a crisis.

    Emerging trends of biotechnology

    In this episode of Harvard Business Review’s Exponential View, Deep Nishar talks with Azeem Azhar about the intersection between genomic technologies and artificial intelligence and the emerging biotech trends that he believes will lead to the next trillion-dollar market.

    Emerging venture capital investment strategies

    At Digital-Life-Design 2020, Deep Nishar discusses the intersection of innovation and investment as it applies to venture capital.

    Leveling the financial playing field

    Join Rishi Khosla as he shares his thoughts on how OakNorth is seeking to unlock capital to help small and medium-sized businesses grow.

    Starting at discovery

    Hear Vivek Ramaswamy describe how Roivant is leveraging the scale of the pharmaceutical industry, and the mentality of a start-up, to help bring new and powerful medicines to market.

    The strategy behind the SoftBank Vision Fund

    At The Milken Institute 2019 Global Conference, Rajeev Misra talks with Michael Milken about the vision behind the fund, the founders we seek to partner with, and how we plan to deploy our capital.


    The information contained in the videos posted on this webpage (the “Information”) serves solely informational purposes, and is not and may not be construed as or relied on in any manner, as legal, business, tax, investment, accounting or other advice or as an offer to sell or a solicitation of an offer to buy limited partnership or comparable limited liability equity interests in SoftBank Vision Fund L.P. (together with, as the context may require, any parallel fund, feeder fund, co-investment vehicle or alternative investment vehicle, “SVF I” or the “Vision Fund I”), or SoftBank Vision Fund II-1 L.P. and SoftBank Vision Fund II-2 L.P. (together with, as the context may require, any parallel fund, feeder fund, co-investment vehicle or alternative investment vehicle, “SVF II” or the “Vision Fund II”, and together with the Vision Fund I, the “Funds”), each managed by SB Investment Advisers (UK) Ltd. (the “Manager” or “SBIA”) and its affiliates. The Information is not intended to be relied upon as the basis for any investment decision, and is not, and should not be assumed to be, complete.

    None of the Vision Fund I, Vision Fund II, or any successor fund managed by SBIA, SBIA, SoftBank Group Corp. (together with its affiliates, “SoftBank”) or their respective affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the Information and nothing contained therein should be relied upon as a promise or representation as to past or future performance of the Vision Fund I, Vision Fund II or any other entity referenced in the Information or future performance of any successor fund managed by SBIA. SBIA, Softbank or any affiliate of the foregoing or any related person shall have no duty or responsibility to provide the visitors to this webpage with any information regarding the business, operations, property, financial and other condition and creditworthiness of any entities, companies or any of their affiliates to the extent they are discussed therein or to update the Information. Visitors to this webpage accept all risks in relying on the Information or any part thereof for any purpose whatsoever.

    Statements contained in the Information (including those relating to current and future market conditions and trends in respect thereof) that are not historical facts are based on current expectations, estimates, projections, opinions and/or beliefs of the individuals making the statements. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. In addition, no representation or warranty is made with respect to the reasonableness of any estimates, forecasts, illustrations, prospects or returns, which should be regarded as illustrative only, or that any profits will be realized. Certain information contained therein constitutes “forward-looking statements” which can be identified by the use of terms such as “may”, “will”, “should”, “expect”, “project”, “estimate”, “intend”, “continue”, “target” or “believe” (or the negatives thereof) or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results or actual performance of any entity referred to therein may differ materially from those reflected or contemplated in such forward-looking statements. As a result, visitors to this webpage should not rely on such forward-looking statements for any reason. Further, any targets stated therein are based on an assumption that economic, market and other conditions will not deteriorate and, in some cases, improve. These projections involve significant elements of subjective judgement. No representation or warranty is made as to future performance or such forward-looking statements.

    See What's Next

    Contact Us